Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/17924
Tipo
ArtículoDerechos de autor
Acceso abierto
Colecciones
Metadatos
Mostrar el registro completo del ítem
ZIKA VIRUS INFECTION INDUCES MITOSIS ABNORMALITIES AND APOPTOTIC CELL DEATH OF HUMAN NEURAL PROGENITOR CELLS
Infecção
Cérebro
Anormalidades do Sistema Nervoso
Humanos
Microcefalia
Infection
Brain
Abnormalities nervous system
Humans
Microcephaly
Autor
Souza, Bruno Solano de Freitas
Sampaio, Gabriela Louise de Almeida
Pereira, Ciro Silveira e
Campos, Gubio Soares
Sardi, Silvia I
Freitas, Luiz Antonio Rodrigues de
Figueira, Claudio Pereira
Paredes, Bruno D
Nonaka, Carolina K V
Azevedo, Carine Machado
Rocha, Vinicius Pinto Costa
Bandeira, Antonio Carlos de Albuquerque
Otero, Rosalia Mendez
Santos, Ricardo Ribeiro dos
Soares, Milena Botelho Pereira
Sampaio, Gabriela Louise de Almeida
Pereira, Ciro Silveira e
Campos, Gubio Soares
Sardi, Silvia I
Freitas, Luiz Antonio Rodrigues de
Figueira, Claudio Pereira
Paredes, Bruno D
Nonaka, Carolina K V
Azevedo, Carine Machado
Rocha, Vinicius Pinto Costa
Bandeira, Antonio Carlos de Albuquerque
Otero, Rosalia Mendez
Santos, Ricardo Ribeiro dos
Soares, Milena Botelho Pereira
Afiliación
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil
Federal University of Bahia. Laboratory of Virology, Salvador, BA, Brasil
Federal University of Bahia. Laboratory of Virology, Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Federal University of Bahia. Department of Pathology. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil
São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
Hospital Couto Maia. Salvador, BA, Brasil
Federal University of Rio de Janeiro. Institute of Biophysics Carlos Chagas Filho. Rio de Janeiro, RJ, Brasil
São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil
Federal University of Bahia. Laboratory of Virology, Salvador, BA, Brasil
Federal University of Bahia. Laboratory of Virology, Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Federal University of Bahia. Department of Pathology. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil
São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
Hospital Couto Maia. Salvador, BA, Brasil
Federal University of Rio de Janeiro. Institute of Biophysics Carlos Chagas Filho. Rio de Janeiro, RJ, Brasil
São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / São Rafael Hospital. Center for Biotechnology and Cell Therapy. Salvador, BA, Brasil
Resumen en ingles
Zika virus (ZIKV) infection has been associated with severe complications both in the developing and adult nervous system. To investigate the deleterious effects of ZIKV infection, we used human neural progenitor cells (NPC), derived from induced pluripotent stem cells (iPSC). We found that NPC are highly susceptible to ZIKV and the infection results in cell death. ZIKV infection led to a marked reduction in cell proliferation, ultrastructural alterations and induction of autophagy. Induction of apoptosis of Sox2(+) cells was demonstrated by activation of caspases 3/7, 8 and 9, and by ultrastructural and flow cytometry analyses. ZIKV-induced death of Sox2(+) cells was prevented by incubation with the pan-caspase inhibitor, Z-VAD-FMK. By confocal microscopy analysis we found an increased number of cells with supernumerary centrosomes. Live imaging showed a significant increase in mitosis abnormalities, including multipolar spindle, chromosome laggards, micronuclei and death of progeny after cell division. FISH analysis for chromosomes 12 and 17 showed increased frequency of aneuploidy, such as monosomy, trisomy and polyploidy. Our study reinforces the link between ZIKV and abnormalities in the developing human brain, including microcephaly.
Palabras clave en portugues
Zika virusInfecção
Cérebro
Anormalidades do Sistema Nervoso
Humanos
Microcefalia
Palabras clave en ingles
Zika VirusInfection
Brain
Abnormalities nervous system
Humans
Microcephaly
Compartir